159 related articles for article (PubMed ID: 32593076)
1. Preoperative vascular heterogeneity and aggressiveness assessment of pituitary macroadenoma based on dynamic contrast-enhanced MRI texture analysis.
Liu YQ; Gao BB; Dong B; Padikkalakandy Cheriyath SS; Song QW; Xu B; Wei Q; Xie LZ; Guo Y; Miao YW
Eur J Radiol; 2020 Aug; 129():109125. PubMed ID: 32593076
[TBL] [Abstract][Full Text] [Related]
2. Quantitative pharmacokinetic analysis of high-temporal-resolution dynamic contrast-enhanced MRI to differentiate the normal-appearing pituitary gland from pituitary macroadenoma.
Kamimura K; Nakajo M; Yoneyama T; Bohara M; Nakanosono R; Fujio S; Iwanaga T; Nickel MD; Imai H; Fukukura Y; Yoshiura T
Jpn J Radiol; 2020 Jul; 38(7):649-657. PubMed ID: 32162178
[TBL] [Abstract][Full Text] [Related]
3. Shape and texture analyses based on conventional MRI for the preoperative prediction of the aggressiveness of pituitary adenomas.
Wang X; Dai Y; Lin H; Cheng J; Zhang Y; Cao M; Zhou Y
Eur Radiol; 2023 May; 33(5):3312-3321. PubMed ID: 36738323
[TBL] [Abstract][Full Text] [Related]
4. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features.
Zhang Y; Chen C; Tian Z; Xu J
Jpn J Radiol; 2020 Dec; 38(12):1125-1134. PubMed ID: 32710133
[TBL] [Abstract][Full Text] [Related]
6. MR textural analysis on contrast enhanced 3D-SPACE images in assessment of consistency of pituitary macroadenoma.
Rui W; Wu Y; Ma Z; Wang Y; Wang Y; Xu X; Zhang J; Yao Z
Eur J Radiol; 2019 Jan; 110():219-224. PubMed ID: 30599863
[TBL] [Abstract][Full Text] [Related]
7. Influence of temporal parameters of DCE-MRI on the quantification of heterogeneity in tumor vascularization.
Crombé A; Saut O; Guigui J; Italiano A; Buy X; Kind M
J Magn Reson Imaging; 2019 Dec; 50(6):1773-1788. PubMed ID: 30980697
[TBL] [Abstract][Full Text] [Related]
8. Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning.
Ugga L; Cuocolo R; Solari D; Guadagno E; D'Amico A; Somma T; Cappabianca P; Del Basso de Caro ML; Cavallo LM; Brunetti A
Neuroradiology; 2019 Dec; 61(12):1365-1373. PubMed ID: 31375883
[TBL] [Abstract][Full Text] [Related]
9. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
[TBL] [Abstract][Full Text] [Related]
10. Early assessment of response to chemotherapy in lung cancer using dynamic contrast-enhanced MRI: a proof-of-concept study.
Xu J; Mei L; Liu L; Wang K; Zhou Z; Zheng J
Clin Radiol; 2018 Jul; 73(7):625-631. PubMed ID: 29571650
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
12. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
13. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
14. Dependence of DCE-MRI biomarker values on analysis algorithm.
Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
[TBL] [Abstract][Full Text] [Related]
15. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
16. [Diagnose pituitary adenoma using dynamic enhanced MRI: a quantitative approach].
Zheng W; Zhai J; Chen Y
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(23):1837-41. PubMed ID: 26712402
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
18. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
19. Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features.
Yao WW; Zhang H; Ding B; Fu T; Jia H; Pang L; Song L; Xu W; Song Q; Chen K; Pan Z
Radiol Med; 2011 Apr; 116(3):366-74. PubMed ID: 21298356
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.
Zhang S; Song G; Zang Y; Jia J; Wang C; Li C; Tian J; Dong D; Zhang Y
Eur Radiol; 2018 Sep; 28(9):3692-3701. PubMed ID: 29572634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
